Author

Robert Ehehalt 1

1 Praxis für Gastroenterologie Prof. Dr. R. Eheha

PROPENSITY SCORE ADJUSTED REAL WORLD EFFECTIVENESS OF VEDOLIZUMAB VS. ANTI-TNF IN BIOLOGIC-NAÏVE CROHN´S DISEASE PATIENTS: INDUCTION PHASE RESULTS FROM THE PROSPECTIVE, OBSERVATIONAL VEDOIBD STUDY IN GERMANY

Bernd Bokemeyer, Romina di Giuseppe, Philipp Efken, Sandra Plachta-Danielzik, Wolfgang Mohl, Axel Schweitzer, Thomas Krause, Martin Hoffstadt, Niels Teich, Raja Atreya, Elisabeth Schnoy, Leo Trentmann, Sina Franzenburg, Petra Hartmann, Robert Ehehalt, Stefan Schreiber

PROPENSITY SCORE ADJUSTED REAL WORLD EFFECTIVENESS OF VEDOLIZUMAB VS. ANTI-TNF IN BIOLOGIC-NAÏVE ULCERATIVE COLITIS PATIENTS: INDUCTION PHASE RESULTS FROM THE PROSPECTIVE, OBSERVATIONAL VEDOIBD STUDY IN GERMANY

Bernd Bokemeyer, Sandra Plachta-Danielzik, Romina di Giuseppe, Philipp Efken, Leo Trentmann, Thomas Krause, Robert Ehehalt, Wolfgang Mohl, Martin Hoffstadt, Axel Schweitzer, Petra Jessen, Sina Franzenburg, Petra Hartmann, Stefan Schreiber

REAL-WORLD EFFECTIVENESS OF VEDOLIZUMAB AND ANTI-TUMOUR NECROSIS FACTOR ALPHA TREATMENT OVER 6 MONTHS IN CROHN'S DISEASE PATIENTS: A GERMAN RETROSPECTIVE CHART REVIEW

Ulf Helwig, Michael Mross, Stefan Schubert, Heinz Hartmann, Alina Brandes, Christian Kempf, Jana Knop, Sarah Campbell-Hill, Robert Ehehalt

REAL-WORLD EFFECTIVENESS OF VEDOLIZUMAB AND ANTI-TUMOUR NECROSIS FACTOR-ALPHA OVER 6 MONTHS IN ULCERATIVE COLITIS PATIENTS: A GERMAN RETROSPECTIVE CHART REVIEW

Ulf Helwig, Michael Mross, Stefan Schubert, Heinz Hartmann, Alina Brandes, Christian Kempf, Jana Knop, Sarah Campbell-Hill, Robert Ehehalt

Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

Jean François Rahier, Fernando Jose Magro Dias, C Abreu, Alessandro Armuzzi, Shomron Ben-Horin, Yehuda Chowers, Mario Cottone, Lissy de Ridder, Glen A Doherty, Robert Ehehalt, Maria Esteve Comas, Konstantinos H. Katsanos, Charlie Lees, E MacMahon, Tom Moreels, Walter Reinisch, Herbert Tilg, L Tremblay, Gigi Veereman, N V

VEDOLIZUMAB FOR INFLAMMATORY BOWEL DISEASE IN CLINICAL PRACTICE – EXPERIENCE FROM A PROSPECTIVE GERMAN REGISTRY

Daniel C. Baumgart, Raja Atreya, Oliver Bachmann, Michael Bläker, Bernd Bokemeyer, Norbert Börner, Jürgen Büning, Axel Dignass, Atylla Drabik, Robert Ehehalt, Andreas Fischer, Franz Hartmann, Heinz Hartmann, Stefanie Howaldt, Petra Jessen, Thomas Krummenerl, Tanja Kuehbacher, Andreas Luegering, Jochen Maul, Michael Mross

Item 1 - 6 / 8
1